Central Nervous System-Acting Drugs Influencing Hypothalamic-Pituitary-Adrenal Axis Function
The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
The hypothalamic-pituitary-adrenal (HPA) axis is a major integrated system that maintains body homeostasis by regulating the neuroendocrine and sympathetic nervous systems and modulating immune function. It is well established that the central nervous system (CNS) integrates responses to different stimuli secreting a specific corticotropin-releasing hormone (CRH) and vasopressin (AVP). In turn, they stimulate the release of ACTH, which induces steroidogenesis in the adrenal gland. The HPA axis is regulated by diurnal rhythms and negative feedback by corticosteroids. Many neurotransmitters and neuropeptides are responsible for the modulation of CRH and AVP neurons. In addition to synthetic glucocorticoids that inhibit the HPA axis, GABA agonists, opioid peptides and endocannabinoids can inhibit cortisol secretion. On the contrary, serotonin, norepinephrine, dopamine, acetylcholine, ghrelin, angiotensin II and different cytokines can stimulate it. It follows that a number of neuroactive drugs, acting as agonists or antagonists on several brain neurotransmitter or neuropeptide receptors, can influence ACTH/cortisol secretion thereby interfering with clinical testing of the functionality of the HPA axis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Arginine vasopressin (AVP) that is co-expressed in some CRH neurons also acts as an ACTH secretagogue. AVP alone has only a slight releasing activity by itself, but it is a potent synergistic releaser in combination with CRH and its role is physiologically relevant in the stress response [25].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [25]
Citations
Cites
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
REUL, J. M. H. M., & KLOET, E. R. D. (1985) · Endocrinology · doi:10.1210/endo-117-6-2505 · Cited by 2,580
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
ANTONI, F. A. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-351 · Cited by 883
Role of brain monoamines and histamine in regulation of anterior pituitary secretion.
Weiner, R. I., & Ganong, W. F. (1978) · Physiological Reviews · doi:10.1152/physrev.1978.58.4.905 · Cited by 696
Corticosteroid–serotonin interactions in the neurobiological mechanisms of stress-related disorders
Lanfumey, L., Mongeau, R., Cohen-Salmon, C., & Hamon, M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.006 · Cited by 341
Effects of cytokines and infections on brain neurochemistry
Dunn, A. J. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.04.002 · Cited by 336
Serotonin activates the hypothalamic–Pituitary–Adrenal axis via serotonin 2C receptor stimulation
Heisler, L. K., Pronchuk, N., Nonogaki, K., Zhou, L., Raber, J., Tung, L., Yeo, G. S. H., O'Rahilly, S., Colmers, W. F., Elmquist, J. K., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2584-06.2007 · Cited by 292
Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Functional role of local GABAergic influences on the HPA axis
Cullinan, W. E., Ziegler, D. R., & Herman, J. P. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0192-2 · Cited by 255
Weiser, M. J., & Handa, R. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.058 · Cited by 250
Exogenous cushing’s syndrome and glucocorticoid withdrawal
Hopkins, R. L., & Leinung, M. C. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.013 · Cited by 224
PLOTSKY, P. M., BRUHN, T. O., & VALE, W. (1985) · Endocrinology · doi:10.1210/endo-117-1-323 · Cited by 196
Miklós, I. H., & Kovács, K. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00147-1 · Cited by 182
The involvement of serotonin in regulation of pituitary-adrenocortical function.
Fuller, R. W. (1992) · PubMed · Cited by 181
Distribution of Serotonin Receptors
PALACIOS, J. M., WAEBER, C., HOYER, D., & MENGOD, G. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16871.x · Cited by 174
Neuroendocrine probes of serotonergic function: A critical review
Yatham, L. N., & Steiner, M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90696-z · Cited by 164
Suda, T., TOZAWA, F., Iwai, I., Sato, Y., Sumitomo, T., Nakano, Y., Yamada, M., & Demura, H. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90094-6 · Cited by 136
Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo—pituitary–adrenal axis
Nussdorfer, G. G., & Malendowicz, L. K. (1998) · Peptides · doi:10.1016/s0196-9781(98)00102-8 · Cited by 125
Malcher‐Lopes, R., Franco, A. J., & Tasker, J. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.033 · Cited by 97
Giordano, R., Pellegrino, M., Picu, A., Bonelli, L., Balbo, M., Berardelli, R., Lanfranco, F., & Ghigo, E. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.09 · Cited by 97
Mann, M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360053005 · Cited by 93
Lachize, S., Apostolakis, E. M., van der Laan, S., Tijssen, A. M. I., Xu, J., de Kloet, E. R., & Meijer, O. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812062106 · Cited by 90
Lerer, B. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00106-7 · Cited by 89
Calogero, A. E., Gallucci, W. T., Bernardini, R., Saoutis, C., Gold, P. W., & Chrousos, G. P. (1988) · Neuroendocrinology · doi:10.1159/000124929 · Cited by 86
Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects
Meltzer, H. Y., & Maes, M. H. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90035-3 · Cited by 80
Iyengar, S., Kim, H. S., & Wood, P. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)91604-0 · Cited by 78
SUMITOMO, T., SUDA, T., NAKANO, Y., TOZAWA, F., YAMADA, M., & DEMURA, H. (1991) · Endocrinology · doi:10.1210/endo-128-5-2248 · Cited by 66
Stress and the pituitary-adrenal axis
Gaillard, R.-C., & Al‐Damluji, S. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80066-6 · Cited by 65
The hypothalamic–pituitary–adrenal axis in asthmatic children
Priftis, K. Ν., Papadimitriou, A., Nicolaidou, P., & Chrousos, G. P. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.10.005 · Cited by 58
Estradiol abolishes autologous down regulation of glucocorticoid receptors in brain
Ferrini, M. G., Lima, A. E., & Nicola, A. F. D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02236-3 · Cited by 58
Zöllner, E. W. (2007) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2007.00539.x · Cited by 56
Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects
Laakmann, G., Schüle, C., Baghai, T. C., & Waldvogel, E. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00029-3 · Cited by 55
Ježová, D. (2005) · Endocrine · doi:10.1385/endo:28:3:287 · Cited by 54
Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron
CALOGERO, A. E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44668.x · Cited by 53
Petraglia, F., Bakalakis, S., Facchinetti, F., Volpe, A., Muller, E. E., & Genazzani, A. R. (1986) · Neuroendocrinology · doi:10.1159/000124663 · Cited by 49
Berlin, I., Warot, D., Legout, V., Guillemant, S., Schöllnhammer, G., & Puech, A. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90038-8 · Cited by 37
Cavagnini, F., Panerai, A. E., VALENTINI, F., Bulgheroni, P., PERACCHI, M., & PINTO, M. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-1-143 · Cited by 36
Ambrogio, A. G., Giraldi, F. P., & Cavagnini, F. (2008) · Pituitary · doi:10.1007/s11102-008-0114-6 · Cited by 35
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
Lotrich, F. E., & Pollock, B. G. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.1.1.17.52301 · Cited by 33
Rhodes, M. E., Billings, T. E., Czambel, R. K., & Rubín, R. T. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01376.x · Cited by 30
Germain, R., Yigit, S., Wells, L., Girotto, J. E., & Salazar, J. C. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.0117 · Cited by 30
Rubín, R. T., Sekula, L. K., O’Toole, S. M., Rhodes, M. E., & Czambel, R. K. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00077-3 · Cited by 28
Kjær, A., Knigge, U., Madsen, E. L., Søe‐Jensen, P., Bach, F. W., & Warberg, J. (1993) · Endocrinology · doi:10.1210/endo.132.5.8386615 · Cited by 25
Hormonal and temperature responses to the 5-HT 1A receptor agonist flesinoxan in normal volunteers
Pitchot, W., Wauthy, J., Hansenne, M., Pinto, E., Fuchs, S., Reggers, J., Legros, J., & Ansseau, M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1177-0 · Cited by 23
Central nitric oxide regulation of the hypothalamic–pituitary–adrenocortical axis in adult male rats
Givalois, L., Li, S., & Pelletier, G. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00218-8 · Cited by 22
Naef, R., Schmid, C., Höfer, M., Minder, S. P., Speich, R., & Boehler, A. (2006) · Respiration · doi:10.1159/000095941 · Cited by 18
EFFECT OF MECLASTINE, A SELECTIVE H1 RECEPTOR ANTAGONIST, UPON ACTH RELEASE
Allolio, B., DEUSS, U., KAULEN, D., & Winkelmann, W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02986.x · Cited by 17
Development of Cushing's syndrome after use of a herbal remedy
Krapf, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11747-8 · Cited by 17
Effects of trazodone on plasma cortisol in normal subjects. A study with drug plasma levels.
Monteleone, P. (1991) · PubMed · Cited by 16
CRF stimulates adenylate cyclase activity in the intermediate lobe of the pituitary gland
Labrie, F., Gagné, B., Lefèvre, G., & Meunier, H. (1983) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(83)90069-2 · Cited by 15
The 5-HTlA receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats
Jenck, F., Martin, J. R., & Moreau, J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300209 · Cited by 15
Bagdy, G., & Arató, M. (1998) · Psychopharmacology · doi:10.1007/s002130050576 · Cited by 14
Garattini, S. K., & Mennini, T. (1988) · International review of neurobiology · doi:10.1016/s0074-7742(08)60089-6 · Cited by 10
Dexamethasone Suppression Test and MMPI Scales
Ansseau, M., von Frenckell, R., Franck, G., Geenen, V. G., & Legros, J. (2008) · Neuropsychobiology · doi:10.1159/000118300 · Cited by 9
Iatrogenic Cushing's syndrome: a different story
Agadi, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12811-5 · Cited by 8
von Bardeleben, U., Holsboer, F., Gerken, A., & Benkert, O. (1989) · PubMed · Cited by 7
Cited by
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Stress and neurodevelopmental processes in the emergence of psychosis
Holtzman, C. W., Trotman, H. D., Goulding, S. M., Ryan, A. T., MacDonald, A. N., Shapiro, D. I., Brasfield, J. L., & Walker, E. F. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.017 · Cited by 244
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
“As well as SCN, important excitatory inputs for CRH secretion also originate from the amygdala and the raphe nuclei (sites of origin of the serotonergic projections) and from the locus coeruleus of the brain stems, where ascending noradrenergic fibers originate [25].”
BackgroundA zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response
Griffiths, B. B., Schoonheim, P. J., Ziv, L., Voelker, L., Baier, H., & Gahtan, E. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00068 · Cited by 143
Ghrelin Indirectly Activates Hypophysiotropic CRF Neurons in Rodents
Cabral, A., Suescun, O., Zigman, J. M., & Perello, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031462 · Cited by 122
Metadata
- Authors
- Locatelli, V., Bresciani, E., Tamiazzo, L., & Torsello, A.
- Affiliations
- University of Milano-Bicocca (IT)
- Venue
- Endocrine development
- Publisher
- S. Karger AG
- Published
- 2009-11-24
- Volume
- 17
- Pages
- 108-120
- ISSN
- 1421-7082 (ISSN-L)
- 1662-2979
- OpenAlex
- W1575747210
- Cited by
- 48
- References
- 58
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 2 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 6 · 2013: 4 · 2012: 6
- FWCI
- 6.08
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Endocrine development (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- hypothalamic-pituitary-adrenal axis, neuroactive drugs, corticotropin-releasing factor, vasopressin, ACTH secretion, cortisol secretion, glucocorticoid negative feedback, diurnal cycle, neuropeptides, neurotransmitters, GABA agonists, opioid peptides, endocannabinoids, serotonin, norepinephrine, dopamine, acetylcholine, ghrelin, angiotensin II, cytokines
- MeSH terms
- Acetylcholine, Catecholamines, Central Nervous System Agents, gamma-Aminobutyric Acid, Glucocorticoids, Histamine, Humans, Hypothalamo-Hypophyseal System, Neuropeptides, Pituitary-Adrenal System, Serotonin, Serotonin Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.